FLT3 and acute myeloid leukemia: analyzed 466 samples from newly diagnosed AML patients as well as from healthy donors and found that cells of the healthy control group had the least, AML patients expressing FLT3-WT had medium, and AML patients with FLT3-ITD expression showed the highest CXCR4 expression (40).